| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-07 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
2e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |